A number of other brokerages also recently weighed in on TRXC. Stifel Nicolaus raised their target price on Transenterix from $3.75 to $4.00 and gave the company a buy rating in a report on Tuesday, October 31st. Ladenburg Thalmann Financial Services set a $5.00 target price on Transenterix and gave the company a buy rating in a report on Friday, October 20th. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the stock. The company has a consensus rating of Hold and an average target price of $2.61.
Shares of Transenterix (NYSEAMERICAN:TRXC) remained flat at $$1.99 during trading hours on Monday. The company had a trading volume of 1,959,453 shares, compared to its average volume of 2,189,200. The firm has a market cap of $408.45, a price-to-earnings ratio of -3.21 and a beta of 2.02. Transenterix has a 52 week low of $0.45 and a 52 week high of $5.00.
In related news, CFO Joseph P. Slattery sold 529,609 shares of the firm’s stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $2.80, for a total transaction of $1,482,905.20. Following the sale, the chief financial officer now owns 440,974 shares of the company’s stock, valued at approximately $1,234,727.20. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Todd Pope sold 600,000 shares of the firm’s stock in a transaction on Wednesday, October 18th. The shares were sold at an average price of $3.68, for a total value of $2,208,000.00. Following the sale, the insider now directly owns 462,644 shares in the company, valued at approximately $1,702,529.92. The disclosure for this sale can be found here. In the last ninety days, insiders sold 1,462,609 shares of company stock worth $4,666,595.
A hedge fund recently raised its stake in Transenterix stock. Ladenburg Thalmann Financial Services Inc. raised its stake in shares of Transenterix Inc (NYSEAMERICAN:TRXC) by 87.8% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 79,150 shares of the medical instruments supplier’s stock after purchasing an additional 37,000 shares during the period. Ladenburg Thalmann Financial Services Inc. owned 0.05% of Transenterix worth $113,000 at the end of the most recent quarter.
TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.
Receive News & Ratings for Transenterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix and related companies with MarketBeat.com's FREE daily email newsletter.